Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


SCHIFF ANDREW N Create: Alert

All | News | Filings
Date FiledTypeDescription
06/05/2023 4 SCHIFF ANDREW N (Director) has filed a Form 4 on Aclaris Therapeutics, Inc.
Txns: Granted 15,750 options to buy @ $8.7, valued at $137k
Granted 4,660 restricted stock units @ $0
Exercised 4,507 restricted stock units @ $0
11/14/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/26/2022 4 SCHIFF ANDREW N (Director) has filed a Form 4 on Aclaris Therapeutics, Inc.
Txns: Sold 14,616 shares @ $17.0078, valued at $248.6k
Sold 12,018 shares @ $17.0175, valued at $204.5k
Sold 14,540 shares @ $17.005, valued at $247.3k
10/19/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/11/2022 4 SCHIFF ANDREW N (Director) has filed a Form 4 on Aclaris Therapeutics, Inc.
Txns: Sold 7,324 shares @ $16.1591, valued at $118.3k
10/06/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/22/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/21/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/16/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/06/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/01/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/28/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/25/2021 4 SCHIFF ANDREW N (Director) has filed a Form 4 on Monte Rosa Therapeutics, Inc.
Txns: Granted 47,132 options to buy @ $19, valued at $895.5k
06/24/2021 3 Form 3 - Initial statement of beneficial ownership of securities:
06/23/2021 3 Form 3 - Initial statement of beneficial ownership of securities:
06/04/2021 4 SCHIFF ANDREW N (Director) has filed a Form 4 on Aclaris Therapeutics, Inc.
Txns: Granted 12,250 options to buy @ $21.9, valued at $268.3k
Granted 3,356 restricted stock units @ $0
06/08/2020 4 SCHIFF ANDREW N (Director) has filed a Form 4 on Aclaris Therapeutics, Inc.
Txns: Granted 16,500 options to buy @ $1.41, valued at $23.3k
Exercised 7,333 restricted stock units @ $0
03/04/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/06/2019 4 Aisling Capital IV, LP (10% Owner) has filed a Form 4 on Zosano Pharma Corp
Txns: Granted 689,655 shares @ $1.45, valued at $1000k
07/15/2019 4 Aisling Capital IV, LP (10% Owner) has filed a Form 4 on SUNESIS PHARMACEUTICALS INC
Txns: Bought 2,500,000 shares @ $0.6, valued at $1.5M
06/10/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/12/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/24/2019 3 Aisling Capital IV, LP (10% Owner) has filed a Form 3 on SUNESIS PHARMACEUTICALS INC
07/12/2018 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/08/2018 4 SCHIFF ANDREW N (Director) has filed a Form 4 on Aclaris Therapeutics, Inc.
Txns: Granted 8,000 options to buy @ $18.35, valued at $146.8k
04/12/2018 3/A Aisling Capital IV, LP (10% Owner) has filed a Form 3/A on Zosano Pharma Corp
04/09/2018 3 Aisling Capital IV, LP (10% Owner) has filed a Form 3 on Zosano Pharma Corp
12/20/2017 4 AISLING CAPITAL III LP (10% Owner) has filed a Form 4 on Loxo Oncology, Inc.
Txns: Sold 250,000 shares @ $80.5, valued at $20.1M
11/27/2017 4 AISLING CAPITAL III LP (10% Owner) has filed a Form 4 on Loxo Oncology, Inc.
Txns: Sold 500,000 shares @ $75, valued at $37.5M
08/16/2017 4 SCHIFF ANDREW N (Director) has filed a Form 4 on Aclaris Therapeutics, Inc.
Txns: Bought 108,601 shares @ $23.02, valued at $2.5M
08/14/2017 4 SCHIFF ANDREW N (Director) has filed a Form 4 on Aclaris Therapeutics, Inc.
Txns: Granted 16,000 options to buy @ $26.97, valued at $431.5k
08/14/2017 3 SCHIFF ANDREW N (Director) has filed a Form 3 on Aclaris Therapeutics, Inc.
05/01/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
01/12/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy